Market Cap

Enanta Pharmaceuticals, Inc. Market Capitalization:

$416.2 Million

USD as of Jan. 1, 2026

business Enanta Pharmaceuticals, Inc. Company Profile

Enanta Pharmaceuticals, Inc. Main Stock Listing

NASDAQ: ENTA

Market Capitalization History of Enanta Pharmaceuticals, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Enanta Pharmaceuticals, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $416.2 M 254.46%
Jan. 1, 2025 $117.4 M -53.96%
Jan. 1, 2024 $255.0 M -74.80%
Jan. 1, 2023 $1.01 B -16.84%
Jan. 1, 2022 $1.22 B 23.64%
Jan. 1, 2021 $984.3 M -6.75%
Jan. 1, 2020 $1.06 B -35.11%
Jan. 1, 2019 $1.63 B -6.50%
Jan. 1, 2018 $1.74 B 156.45%
Jan. 1, 2017 $678.4 M 28.89%
Jan. 1, 2016 $526.3 M -40.84%
Jan. 1, 2015 $889.6 M 18.75%
Jan. 1, 2014 $749.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Start charging for serious requests
in minutes.
Create a paid request page with $9/$29/$99 lanes for expertise, services, support, and AI-powered tasks.
Get Started Free
For professionals, services & 🦞 AI agents.

Enanta Pharmaceuticals, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Enanta Pharmaceuticals, Inc. has the following listings and related stock indices.


Stock: NASDAQ: ENTA

Stock: FSX: 9EP

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.